Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.45 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.45 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.45 |
| ▸ | P2RY10 | O00398 | 5/20 | 0.44 |
| ▸ | GPR174 | Q9BXC1 | 5/20 | 0.44 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.44 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28207261 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL30063078 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL16294197 | 0.86 | P2RY10 (0.56) | P2RY10GPR174GPR34 | |
| SCHEMBL162609 | 0.86 | P2RY10 (0.56) | P2RY10GPR174GPR34 | |
| SCHEMBL16293534 | 0.86 | P2RY10 (0.56) | P2RY10GPR174GPR34 | |
| SCHEMBL9952582 | 0.86 | P2RY10 (0.56) | P2RY10GPR174GPR34 | |
| SCHEMBL3963403 | 0.84 | PLA2G2C (0.43) | LPAR1LPAR4LPAR5LPAR2LPAR3 | |
| SCHEMBL17144721 | 0.84 | PLA2G2C (0.43) | LPAR1LPAR4LPAR5LPAR2LPAR3 | |
| SCHEMBL19410782 | 0.84 | PLA2G2C (0.43) | LPAR1LPAR4LPAR5LPAR2LPAR3 | |
| SCHEMBL226745 | 0.84 | PLA2G2C (0.43) | LPAR1LPAR4LPAR5LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230241246-A1 | NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEM | ADEIRA PHARMA, LLC | 2023-08-03 | — | — | US | disclosed |
| EP-4031127-A1 | NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEM | Adeira Pharma, LLC (US) | 2022-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230241246-A1 | NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEM | HPN, ABCB1, NPPA | KDM4E 4586/4885DUSP3 711/4885MEN1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.